BioMarin Pharmaceutical Inc.

EDGAR

Annual consolidated revenue for 2025: about USD 3.221B, using the latest reported figures. The previous period, 2024, was about USD 2.854B.

Watchlist

Latest quarter

Revenue

990 million USD

2026 Q2 · USD

Exact inputs and evidence

Operating margin

11.21%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: 110920000 USD Source
  • Revenue: 989708000 USD Source

Operating cash flow

168 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: 388760000 USD Source
  • Operating Cash Flow: 220651000 USD Source

Free cash flow

139 million USD

2026 Q2 · USD

Exact inputs and evidence
  • Operating Cash Flow: 388760000 USD Source
  • Operating Cash Flow: 220651000 USD Source
  • Capital Expenditure: 49739000 USD Source
  • Capital Expenditure: 20923000 USD Source
Cash and cash equivalents
874 million USD Source
Exact value

874005000 USD

Long-term debt including current maturities
4.19 billion USD Source
Exact value

4186142000 USD

Shares outstanding
194 million shares Source
Exact value

193535556 shares

Reported share-count change

0.80% · 1.53 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 192001650 shares · 2025-06-30· Source
  • 193535556 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

3.41 billion USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Revenue: 776133000 USD · 2025-07-01 – 2025-09-30 Source
  • Revenue: 3221253000 USD · 2025-01-01 – 2025-12-31 Source
  • Revenue: 2346688000 USD · 2025-01-01 – 2025-09-30 Source
  • Revenue: 766208000 USD · 2026-01-01 – 2026-03-31 Source
  • Revenue: 989708000 USD · 2026-04-01 – 2026-06-30 Source

Net income

73 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -30744000 USD · 2025-07-01 – 2025-09-30 Source
  • Net income: 348901000 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: 395474000 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: 105527000 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: 44762000 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

857 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: 728350000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 359665000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: 827994000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 728350000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 220651000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: 388760000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: 220651000 USD · 2026-01-01 – 2026-03-31 Source

Capital expenditure

119 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Capital expenditure: 62316000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 33869000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 103038000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 62316000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 20923000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 49739000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 20923000 USD · 2026-01-01 – 2026-03-31 Source

Free cash flow

738 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: 728350000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 359665000 USD · 2025-01-01 – 2025-06-30 Source
  • Operating cash flow: 827994000 USD · 2025-01-01 – 2025-12-31 Source
  • Operating cash flow: 728350000 USD · 2025-01-01 – 2025-09-30 Source
  • Operating cash flow: 220651000 USD · 2026-01-01 – 2026-03-31 Source
  • Operating cash flow: 388760000 USD · 2026-01-01 – 2026-06-30 Source
  • Operating cash flow: 220651000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 62316000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 33869000 USD · 2025-01-01 – 2025-06-30 Source
  • Capital expenditure: 103038000 USD · 2025-01-01 – 2025-12-31 Source
  • Capital expenditure: 62316000 USD · 2025-01-01 – 2025-09-30 Source
  • Capital expenditure: 20923000 USD · 2026-01-01 – 2026-03-31 Source
  • Capital expenditure: 49739000 USD · 2026-01-01 – 2026-06-30 Source
  • Capital expenditure: 20923000 USD · 2026-01-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-06.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 11 of 11 periods available· newest 2025-12-31
  • Operating income: 11 of 11 periods available· newest 2025-12-31
  • Net income: 11 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 11 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 11 of 11 periods available· newest 2025-12-31
  • Total assets: 11 of 11 periods available· newest 2025-12-31
  • Total liabilities: 11 of 11 periods available· newest 2025-12-31
  • Current assets: 11 of 11 periods available· newest 2025-12-31
  • Current liabilities: 11 of 11 periods available· newest 2025-12-31
  • Cash and cash equivalents: 11 of 11 periods available· newest 2025-12-31
  • Long-term debt including current maturities: 1 of 11 periods available· newest 2025-12-31
  • Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    +12.9%

    Prior period

    USD 2.85 billion

    –

    Current period

    USD 3.22 billion

    –

    Exact inputs and evidence

    3221253000 − 2853915000 = 367338000 USD

    2853915000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    3221253000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    -18.3%

    Prior period

    USD 426.86 million

    –

    Current period

    USD 348.9 million

    –

    Exact inputs and evidence

    348901000 − 426859000 = -77958000 USD

    426859000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    348901000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +44.5%

    Prior period

    USD 572.84 million

    –

    Current period

    USD 827.99 million

    –

    Exact inputs and evidence

    827994000 − 572841000 = 255153000 USD

    572841000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    827994000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +20.6%

    Prior period

    USD 85.42 million

    –

    Current period

    USD 103.04 million

    –

    Exact inputs and evidence

    103038000 − 85424000 = 17614000 USD

    85424000 USD · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    103038000 USD · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue USD 3.22 billion 100% of revenue
  • Cost of revenue USD 717.44 million 22% of revenue
  • Operating expenses USD 2.07 billion 64% of revenue
  • Other operating costs Derived USD 19.39 million 0.6% of revenue
  • Operating income USD 409.48 million 13% of revenue
  • Tax, interest and other Derived USD 60.58 million 1.9% of revenue
  • Net income USD 348.9 million 11% of revenue

Cash

  • Operating cash flow USD 827.99 million 26% of revenue
  • Capital expenditure USD 103.04 million 3.2% of revenue
  • Free cash flow Derived USD 724.96 million 23% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2016 Operating loss: operating costs were 172% of revenue.
  • 2017 Operating loss: operating costs were 101% of revenue.
  • 2018 Operating loss: operating costs were 108% of revenue.
  • 2019 Operating loss: operating costs were 106% of revenue.
  • 2020 Operating loss: operating costs were 102% of revenue.
  • 2021 Operating loss: operating costs were 104% of revenue.
  • 2022 92%
  • 2023 92%
  • 2024 15%83%
  • 2025 11%87%
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2016 2016-01-01 – 2016-12-311116854000 1920283000 Derived -803429000 -173219000 Derived -630210000 -376217000 Derived
Source
2017 2017-01-01 – 2017-12-311313646000 1328346000 Derived -14700000 102342000 Derived -117042000 -207976000 Derived
Source
2018 2018-01-01 – 2018-12-311491212000 1614736000 Derived -123524000 -46313000 Derived -77211000 -124412000 Derived
Source
2019 2019-01-01 – 2019-12-311704048000 1804505000 Derived -100457000 -76609000 Derived -23848000 -96764000 Derived
Source
2020 2020-01-01 – 2020-12-311860455000 1903895000 Derived -43440000 -897469000 Derived 854029000 -28947000 Derived
Source
2021 2021-01-01 – 2021-12-311846275000 1928616000 Derived -82341000 -18261000 Derived -64080000 208958000 Derived
Source
2022 2022-01-01 – 2022-12-312096039000 1935065000 Derived 160974000 19413000 Derived 141561000 54943000 Derived
Source
2023 2023-01-01 – 2023-12-312419226000 2233452000 Derived 185774000 18129000 Derived 167645000 62568000 Derived
Source
2024 2024-01-01 – 2024-12-312853915000 2369701000 Derived 484214000 57355000 Derived 426859000 487417000 Derived
Source
2025 2025-01-01 – 2025-12-313221253000 2811775000 Derived 409478000 60577000 Derived 348901000 724956000 Derived
Source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3.2B 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.3.5B2.6B1.7B869.7M0.0201620212025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Revenue1116854000
2017Revenue1313646000
2018Revenue1491212000
2019Revenue1704048000
2020Revenue1860455000
2021Revenue1846275000
2022Revenue2096039000
2023Revenue2419226000
2024Revenue2853915000
2025Revenue3221253000

Revenue growth

Change in revenue from the same financial period one year earlier.

12.9% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.27.6%20.0%12.4%4.8%-2.9%201620212025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2016Year over year25.5%
2017Year over year17.6%
2018Year over year13.5%
2019Year over year14.3%
2020Year over year9.2%
2021Year over year-0.8%
2022Year over year13.5%
2023Year over year15.4%
2024Year over year18%
2025Year over year12.9%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 12.7% 2025
Net margin 10.8% 2025
Free cash flow margin 22.5% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.55%21%-13%-47%-81%201620212025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2016Operating margin-71.9%
2017Operating margin-1.1%
2018Operating margin-8.3%
2019Operating margin-5.9%
2020Operating margin-2.3%
2021Operating margin-4.5%
2022Operating margin7.7%
2023Operating margin7.7%
2024Operating margin17%
2025Operating margin12.7%
2016Net margin-56.4%
2017Net margin-8.9%
2018Net margin-5.2%
2019Net margin-1.4%
2020Net margin45.9%
2021Net margin-3.5%
2022Net margin6.8%
2023Net margin6.9%
2024Net margin15%
2025Net margin10.8%
2016Free cash flow margin-33.7%
2017Free cash flow margin-15.8%
2018Free cash flow margin-8.3%
2019Free cash flow margin-5.7%
2020Free cash flow margin-1.6%
2021Free cash flow margin11.3%
2022Free cash flow margin2.6%
2023Free cash flow margin2.6%
2024Free cash flow margin17.1%
2025Free cash flow margin22.5%

Operating cash flow

Cash generated by the company’s normal business operations.

USD 828M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.912.5M606.3M300.1M-6.1M-312.3M201620212025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Operating cash flow-227837000
2017Operating cash flow-8757000
2018Operating cash flow20208000
2019Operating cash flow48262000
2020Operating cash flow85365000
2021Operating cash flow304536000
2022Operating cash flow175902000
2023Operating cash flow159259000
2024Operating cash flow572841000
2025Operating cash flow827994000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 725M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.813.0M493.7M174.4M-145.0M-464.3M201620212025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence
2016Free cash flow-376217000
2017Free cash flow-207976000
2018Free cash flow-124412000
2019Free cash flow-96764000
2020Free cash flow-28947000
2021Free cash flow208958000
2022Free cash flow54943000
2023Free cash flow62568000
2024Free cash flow487417000
2025Free cash flow724956000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

19.8% 2025
Liabilities to assets historyTotal liabilities as a share of total assets. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.43%32%21%11%0%201620212025
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2016Liabilities / assets31.3%
2017Liabilities / assets39.4%
2018Liabilities / assets33%
2019Liabilities / assets33.4%
2020Liabilities / assets29.8%
2021Liabilities / assets29%
2022Liabilities / assets27.8%
2023Liabilities / assets27.6%
2024Liabilities / assets19%
2025Liabilities / assets19.8%

Current assets to current liabilities

Current assets divided by current liabilities.

5.21× 2025
Current assets to current liabilities historyCurrent assets divided by current liabilities. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.5.75×4.31×2.88×1.44×0.00×201620212025
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2016Current assets / current liabilities3.24×
2017Current assets / current liabilities2.7×
2018Current assets / current liabilities3.93×
2019Current assets / current liabilities2.08×
2020Current assets / current liabilities4.76×
2021Current assets / current liabilities4.16×
2022Current assets / current liabilities4.67×
2023Current assets / current liabilities2.51×
2024Current assets / current liabilities5.33×
2025Current assets / current liabilities5.21×

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2016 2016-01-01 – 2016-12-31
−USD 630.21 million
Exact value

Exact value: -630210000 USD

2016-01-01 – 2016-12-31: -630210000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 227.84 million
Exact value

Exact value: -227837000 USD

2016-01-01 – 2016-12-31: -227837000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 148.38 million
Exact value

Exact value: 148380000 USD

2016-01-01 – 2016-12-31: 148380000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 376.22 million
Calculation and evidence

-227837000 − 148380000 USD

Exact free cash flow: -376217000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2017 2017-01-01 – 2017-12-31
−USD 117.04 million
Exact value

Exact value: -117042000 USD

2017-01-01 – 2017-12-31: -117042000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.76 million
Exact value

Exact value: -8757000 USD

2017-01-01 – 2017-12-31: -8757000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 199.22 million
Exact value

Exact value: 199219000 USD

2017-01-01 – 2017-12-31: 199219000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 207.98 million
Calculation and evidence

-8757000 − 199219000 USD

Exact free cash flow: -207976000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2018 2018-01-01 – 2018-12-31
−USD 77.21 million
Exact value

Exact value: -77211000 USD

2018-01-01 – 2018-12-31: -77211000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 20.21 million
Exact value

Exact value: 20208000 USD

2018-01-01 – 2018-12-31: 20208000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 144.62 million
Exact value

Exact value: 144620000 USD

2018-01-01 – 2018-12-31: 144620000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 124.41 million
Calculation and evidence

20208000 − 144620000 USD

Exact free cash flow: -124412000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2019 2019-01-01 – 2019-12-31
−USD 23.85 million
Exact value

Exact value: -23848000 USD

2019-01-01 – 2019-12-31: -23848000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 48.26 million
Exact value

Exact value: 48262000 USD

2019-01-01 – 2019-12-31: 48262000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 145.03 million
Exact value

Exact value: 145026000 USD

2019-01-01 – 2019-12-31: 145026000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 96.76 million
Calculation and evidence

48262000 − 145026000 USD

Exact free cash flow: -96764000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2020 2020-01-01 – 2020-12-31
USD 854.03 million
Exact value

Exact value: 854029000 USD

2020-01-01 – 2020-12-31: 854029000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 85.37 million
Exact value

Exact value: 85365000 USD

2020-01-01 – 2020-12-31: 85365000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 114.31 million
Exact value

Exact value: 114312000 USD

2020-01-01 – 2020-12-31: 114312000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 28.95 million
Calculation and evidence

85365000 − 114312000 USD

Exact free cash flow: -28947000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2021 2021-01-01 – 2021-12-31
−USD 64.08 million
Exact value

Exact value: -64080000 USD

2021-01-01 – 2021-12-31: -64080000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 304.54 million
Exact value

Exact value: 304536000 USD

2021-01-01 – 2021-12-31: 304536000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 95.58 million
Exact value

Exact value: 95578000 USD

2021-01-01 – 2021-12-31: 95578000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 208.96 million
Calculation and evidence

304536000 − 95578000 USD

Exact free cash flow: 208958000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2022 2022-01-01 – 2022-12-31
USD 141.56 million
Exact value

Exact value: 141561000 USD

2022-01-01 – 2022-12-31: 141561000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 175.9 million
Exact value

Exact value: 175902000 USD

2022-01-01 – 2022-12-31: 175902000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 120.96 million
Exact value

Exact value: 120959000 USD

2022-01-01 – 2022-12-31: 120959000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 54.94 million
Calculation and evidence

175902000 − 120959000 USD

Exact free cash flow: 54943000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2023 2023-01-01 – 2023-12-31
USD 167.65 million
Exact value

Exact value: 167645000 USD

2023-01-01 – 2023-12-31: 167645000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 159.26 million
Exact value

Exact value: 159259000 USD

2023-01-01 – 2023-12-31: 159259000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 96.69 million
Exact value

Exact value: 96691000 USD

2023-01-01 – 2023-12-31: 96691000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 62.57 million
Calculation and evidence

159259000 − 96691000 USD

Exact free cash flow: 62568000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2024 2024-01-01 – 2024-12-31
USD 426.86 million
Exact value

Exact value: 426859000 USD

2024-01-01 – 2024-12-31: 426859000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 572.84 million
Exact value

Exact value: 572841000 USD

2024-01-01 – 2024-12-31: 572841000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 85.42 million
Exact value

Exact value: 85424000 USD

2024-01-01 – 2024-12-31: 85424000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 487.42 million
Calculation and evidence

572841000 − 85424000 USD

Exact free cash flow: 487417000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
USD 348.9 million
Exact value

Exact value: 348901000 USD

2025-01-01 – 2025-12-31: 348901000 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 827.99 million
Exact value

Exact value: 827994000 USD

2025-01-01 – 2025-12-31: 827994000 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 103.04 million
Exact value

Exact value: 103038000 USD

2025-01-01 – 2025-12-31: 103038000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 724.96 million
Calculation and evidence

827994000 − 103038000 USD

Exact free cash flow: 724956000 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

264 filings · 5,909 latest values · 5,909 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001048477, 1048477, BMRN, bmrn, edgar:1048477

Also known as BIOMARIN PHARMACEUTICAL INC, BioMarin Pharmaceutical Inc, BioMarin Pharmaceutical Inc.